SCHEMBL12469491

SCHEMBL12469491

CNC(=S)c1cnn2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.49
RAB9A P51151 8/20 0.49
ALDH1A1 P00352 8/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
MAPT P10636 2/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KLF5 Q13887 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
EPHB3 P54753 5/20 0.48
RIPK2 O43353 1/20 0.48
LCK P06239 1/20 0.48
KDM4E B2RXH2 6/20 0.47
HTT P42858 3/20 0.47
TP53 P04637 2/20 0.47
LMNA P02545 1/20 0.47
HSD17B10 Q99714 2/20 0.44
IRAK4 Q9NWZ3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6121120 0.81 NPC1 (0.63) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL956445 0.78 EPHB3 (0.48) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1286674 0.75 NPC1 (0.68) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1863799 0.74 NPC1 (0.58) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL17867589 0.73 NPC1 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL416200 0.73 EPHB3 (0.56) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL6450616 0.72 NPC1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL30152645 0.71 EPHB3 (0.55) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL1044120 0.71 EPHB3 (0.58) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL11300658 0.71 EPHB3 (0.55) NPC1RAB9AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627181-A2 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-08-21 EP disclosed
WO-2012051410-A2 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 WO disclosed